Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
17,819
archived clinical trials in
Brain Cancer

A Study of Rindopepimut/GM-CSF in Patients With Relapsed EGFRvIII-Positive Glioblastoma
A Phase II Study of Rindopepimut/GM-CSF in Patients With Relapsed EGFRvIII-Positive Glioblastoma
Status: Enrolling
Updated:  4/6/2017
2036
mi
from 91732
Cleveland, OH
A Study of Rindopepimut/GM-CSF in Patients With Relapsed EGFRvIII-Positive Glioblastoma
A Phase II Study of Rindopepimut/GM-CSF in Patients With Relapsed EGFRvIII-Positive Glioblastoma
Status: Enrolling
Updated: 4/6/2017
University Hospitals Seidman Cancer Center
2036
mi
from 91732
Cleveland, OH
Click here to add this to my saved trials
A Study of Rindopepimut/GM-CSF in Patients With Relapsed EGFRvIII-Positive Glioblastoma
A Phase II Study of Rindopepimut/GM-CSF in Patients With Relapsed EGFRvIII-Positive Glioblastoma
Status: Enrolling
Updated:  4/6/2017
2576
mi
from 91732
Boston, MA
A Study of Rindopepimut/GM-CSF in Patients With Relapsed EGFRvIII-Positive Glioblastoma
A Phase II Study of Rindopepimut/GM-CSF in Patients With Relapsed EGFRvIII-Positive Glioblastoma
Status: Enrolling
Updated: 4/6/2017
Dana-Farber Cancer Institute and Mass General Hospital
2576
mi
from 91732
Boston, MA
Click here to add this to my saved trials
A Study of Rindopepimut/GM-CSF in Patients With Relapsed EGFRvIII-Positive Glioblastoma
A Phase II Study of Rindopepimut/GM-CSF in Patients With Relapsed EGFRvIII-Positive Glioblastoma
Status: Enrolling
Updated:  4/6/2017
2185
mi
from 91732
Amherst, NY
A Study of Rindopepimut/GM-CSF in Patients With Relapsed EGFRvIII-Positive Glioblastoma
A Phase II Study of Rindopepimut/GM-CSF in Patients With Relapsed EGFRvIII-Positive Glioblastoma
Status: Enrolling
Updated: 4/6/2017
Dent Neurologic Institute, 3980 Sheridan Dr, 3rd Flr Clinical Rsch
2185
mi
from 91732
Amherst, NY
Click here to add this to my saved trials
A Study of Rindopepimut/GM-CSF in Patients With Relapsed EGFRvIII-Positive Glioblastoma
A Phase II Study of Rindopepimut/GM-CSF in Patients With Relapsed EGFRvIII-Positive Glioblastoma
Status: Enrolling
Updated:  4/6/2017
2430
mi
from 91732
Hackensack, NJ
A Study of Rindopepimut/GM-CSF in Patients With Relapsed EGFRvIII-Positive Glioblastoma
A Phase II Study of Rindopepimut/GM-CSF in Patients With Relapsed EGFRvIII-Positive Glioblastoma
Status: Enrolling
Updated: 4/6/2017
Hackensack University Medical Center
2430
mi
from 91732
Hackensack, NJ
Click here to add this to my saved trials
A Study of Rindopepimut/GM-CSF in Patients With Relapsed EGFRvIII-Positive Glioblastoma
A Phase II Study of Rindopepimut/GM-CSF in Patients With Relapsed EGFRvIII-Positive Glioblastoma
Status: Enrolling
Updated:  4/6/2017
1509
mi
from 91732
Minneapolis, MN
A Study of Rindopepimut/GM-CSF in Patients With Relapsed EGFRvIII-Positive Glioblastoma
A Phase II Study of Rindopepimut/GM-CSF in Patients With Relapsed EGFRvIII-Positive Glioblastoma
Status: Enrolling
Updated: 4/6/2017
John Nasseff Neuroscience Institute, Abbott Northwestern Hospital, 800 e. 28th Str. MR
1509
mi
from 91732
Minneapolis, MN
Click here to add this to my saved trials
A Study of Rindopepimut/GM-CSF in Patients With Relapsed EGFRvIII-Positive Glioblastoma
A Phase II Study of Rindopepimut/GM-CSF in Patients With Relapsed EGFRvIII-Positive Glioblastoma
Status: Enrolling
Updated:  4/6/2017
15
mi
from 91732
Los Angeles, CA
A Study of Rindopepimut/GM-CSF in Patients With Relapsed EGFRvIII-Positive Glioblastoma
A Phase II Study of Rindopepimut/GM-CSF in Patients With Relapsed EGFRvIII-Positive Glioblastoma
Status: Enrolling
Updated: 4/6/2017
Kaiser Permanente Los Angeles Medical Center
15
mi
from 91732
Los Angeles, CA
Click here to add this to my saved trials
A Study of Rindopepimut/GM-CSF in Patients With Relapsed EGFRvIII-Positive Glioblastoma
A Phase II Study of Rindopepimut/GM-CSF in Patients With Relapsed EGFRvIII-Positive Glioblastoma
Status: Enrolling
Updated:  4/6/2017
827
mi
from 91732
Portland, OR
A Study of Rindopepimut/GM-CSF in Patients With Relapsed EGFRvIII-Positive Glioblastoma
A Phase II Study of Rindopepimut/GM-CSF in Patients With Relapsed EGFRvIII-Positive Glioblastoma
Status: Enrolling
Updated: 4/6/2017
Legacy Research Institute
827
mi
from 91732
Portland, OR
Click here to add this to my saved trials
A Study of Rindopepimut/GM-CSF in Patients With Relapsed EGFRvIII-Positive Glioblastoma
A Phase II Study of Rindopepimut/GM-CSF in Patients With Relapsed EGFRvIII-Positive Glioblastoma
Status: Enrolling
Updated:  4/6/2017
2355
mi
from 91732
Allentown, PA
A Study of Rindopepimut/GM-CSF in Patients With Relapsed EGFRvIII-Positive Glioblastoma
A Phase II Study of Rindopepimut/GM-CSF in Patients With Relapsed EGFRvIII-Positive Glioblastoma
Status: Enrolling
Updated: 4/6/2017
Lehigh Valley Hospital-John and Dorothy Morgan Cancer Center
2355
mi
from 91732
Allentown, PA
Click here to add this to my saved trials
A Study of Rindopepimut/GM-CSF in Patients With Relapsed EGFRvIII-Positive Glioblastoma
A Phase II Study of Rindopepimut/GM-CSF in Patients With Relapsed EGFRvIII-Positive Glioblastoma
Status: Enrolling
Updated:  4/6/2017
2316
mi
from 91732
Hollywood, FL
A Study of Rindopepimut/GM-CSF in Patients With Relapsed EGFRvIII-Positive Glioblastoma
A Phase II Study of Rindopepimut/GM-CSF in Patients With Relapsed EGFRvIII-Positive Glioblastoma
Status: Enrolling
Updated: 4/6/2017
Memorial Cancer Institute
2316
mi
from 91732
Hollywood, FL
Click here to add this to my saved trials
A Study of Rindopepimut/GM-CSF in Patients With Relapsed EGFRvIII-Positive Glioblastoma
A Phase II Study of Rindopepimut/GM-CSF in Patients With Relapsed EGFRvIII-Positive Glioblastoma
Status: Enrolling
Updated:  4/6/2017
2413
mi
from 91732
Edison, NJ
A Study of Rindopepimut/GM-CSF in Patients With Relapsed EGFRvIII-Positive Glioblastoma
A Phase II Study of Rindopepimut/GM-CSF in Patients With Relapsed EGFRvIII-Positive Glioblastoma
Status: Enrolling
Updated: 4/6/2017
New Jersey Neuroscience Institute, JFK Medical Center
2413
mi
from 91732
Edison, NJ
Click here to add this to my saved trials
A Study of Rindopepimut/GM-CSF in Patients With Relapsed EGFRvIII-Positive Glioblastoma
A Phase II Study of Rindopepimut/GM-CSF in Patients With Relapsed EGFRvIII-Positive Glioblastoma
Status: Enrolling
Updated:  4/6/2017
1728
mi
from 91732
Evanston, IL
A Study of Rindopepimut/GM-CSF in Patients With Relapsed EGFRvIII-Positive Glioblastoma
A Phase II Study of Rindopepimut/GM-CSF in Patients With Relapsed EGFRvIII-Positive Glioblastoma
Status: Enrolling
Updated: 4/6/2017
NorthShore University Health System
1728
mi
from 91732
Evanston, IL
Click here to add this to my saved trials
A Study of Rindopepimut/GM-CSF in Patients With Relapsed EGFRvIII-Positive Glioblastoma
A Phase II Study of Rindopepimut/GM-CSF in Patients With Relapsed EGFRvIII-Positive Glioblastoma
Status: Enrolling
Updated:  4/6/2017
2184
mi
from 91732
Orlando, FL
A Study of Rindopepimut/GM-CSF in Patients With Relapsed EGFRvIII-Positive Glioblastoma
A Phase II Study of Rindopepimut/GM-CSF in Patients With Relapsed EGFRvIII-Positive Glioblastoma
Status: Enrolling
Updated: 4/6/2017
Orlando Health
2184
mi
from 91732
Orlando, FL
Click here to add this to my saved trials
A Study of Rindopepimut/GM-CSF in Patients With Relapsed EGFRvIII-Positive Glioblastoma
A Phase II Study of Rindopepimut/GM-CSF in Patients With Relapsed EGFRvIII-Positive Glioblastoma
Status: Enrolling
Updated:  4/6/2017
1919
mi
from 91732
Atlanta, GA
A Study of Rindopepimut/GM-CSF in Patients With Relapsed EGFRvIII-Positive Glioblastoma
A Phase II Study of Rindopepimut/GM-CSF in Patients With Relapsed EGFRvIII-Positive Glioblastoma
Status: Enrolling
Updated: 4/6/2017
Piedmont Atlanta Hospital
1919
mi
from 91732
Atlanta, GA
Click here to add this to my saved trials
A Study of Rindopepimut/GM-CSF in Patients With Relapsed EGFRvIII-Positive Glioblastoma
A Phase II Study of Rindopepimut/GM-CSF in Patients With Relapsed EGFRvIII-Positive Glioblastoma
Status: Enrolling
Updated:  4/6/2017
2562
mi
from 91732
Providence, RI
A Study of Rindopepimut/GM-CSF in Patients With Relapsed EGFRvIII-Positive Glioblastoma
A Phase II Study of Rindopepimut/GM-CSF in Patients With Relapsed EGFRvIII-Positive Glioblastoma
Status: Enrolling
Updated: 4/6/2017
Rhode Island Hospital
2562
mi
from 91732
Providence, RI
Click here to add this to my saved trials
A Study of Rindopepimut/GM-CSF in Patients With Relapsed EGFRvIII-Positive Glioblastoma
A Phase II Study of Rindopepimut/GM-CSF in Patients With Relapsed EGFRvIII-Positive Glioblastoma
Status: Enrolling
Updated:  4/6/2017
1726
mi
from 91732
Chicago, IL
A Study of Rindopepimut/GM-CSF in Patients With Relapsed EGFRvIII-Positive Glioblastoma
A Phase II Study of Rindopepimut/GM-CSF in Patients With Relapsed EGFRvIII-Positive Glioblastoma
Status: Enrolling
Updated: 4/6/2017
Rush University Medical Center
1726
mi
from 91732
Chicago, IL
Click here to add this to my saved trials
A Study of Rindopepimut/GM-CSF in Patients With Relapsed EGFRvIII-Positive Glioblastoma
A Phase II Study of Rindopepimut/GM-CSF in Patients With Relapsed EGFRvIII-Positive Glioblastoma
Status: Enrolling
Updated:  4/6/2017
1891
mi
from 91732
Lansing, MI
A Study of Rindopepimut/GM-CSF in Patients With Relapsed EGFRvIII-Positive Glioblastoma
A Phase II Study of Rindopepimut/GM-CSF in Patients With Relapsed EGFRvIII-Positive Glioblastoma
Status: Enrolling
Updated: 4/6/2017
Sparrow Cancer Center
1891
mi
from 91732
Lansing, MI
Click here to add this to my saved trials
A Study of Rindopepimut/GM-CSF in Patients With Relapsed EGFRvIII-Positive Glioblastoma
A Phase II Study of Rindopepimut/GM-CSF in Patients With Relapsed EGFRvIII-Positive Glioblastoma
Status: Enrolling
Updated:  4/6/2017
343
mi
from 91732
Phoenix, AZ
A Study of Rindopepimut/GM-CSF in Patients With Relapsed EGFRvIII-Positive Glioblastoma
A Phase II Study of Rindopepimut/GM-CSF in Patients With Relapsed EGFRvIII-Positive Glioblastoma
Status: Enrolling
Updated: 4/6/2017
St. Joseph's Hospital and Medical Center / Barrow Neurological Institute
343
mi
from 91732
Phoenix, AZ
Click here to add this to my saved trials
A Study of Rindopepimut/GM-CSF in Patients With Relapsed EGFRvIII-Positive Glioblastoma
A Phase II Study of Rindopepimut/GM-CSF in Patients With Relapsed EGFRvIII-Positive Glioblastoma
Status: Enrolling
Updated:  4/6/2017
328
mi
from 91732
Stanford, CA
A Study of Rindopepimut/GM-CSF in Patients With Relapsed EGFRvIII-Positive Glioblastoma
A Phase II Study of Rindopepimut/GM-CSF in Patients With Relapsed EGFRvIII-Positive Glioblastoma
Status: Enrolling
Updated: 4/6/2017
Stanford Cancer Institute, Stanford University
328
mi
from 91732
Stanford, CA
Click here to add this to my saved trials
A Study of Rindopepimut/GM-CSF in Patients With Relapsed EGFRvIII-Positive Glioblastoma
A Phase II Study of Rindopepimut/GM-CSF in Patients With Relapsed EGFRvIII-Positive Glioblastoma
Status: Enrolling
Updated:  4/6/2017
2503
mi
from 91732
Stony Brook, NY
A Study of Rindopepimut/GM-CSF in Patients With Relapsed EGFRvIII-Positive Glioblastoma
A Phase II Study of Rindopepimut/GM-CSF in Patients With Relapsed EGFRvIII-Positive Glioblastoma
Status: Enrolling
Updated: 4/6/2017
Stony Brook University Hospital
2503
mi
from 91732
Stony Brook, NY
Click here to add this to my saved trials
A Study of Rindopepimut/GM-CSF in Patients With Relapsed EGFRvIII-Positive Glioblastoma
A Phase II Study of Rindopepimut/GM-CSF in Patients With Relapsed EGFRvIII-Positive Glioblastoma
Status: Enrolling
Updated:  4/6/2017
961
mi
from 91732
Seattle, WA
A Study of Rindopepimut/GM-CSF in Patients With Relapsed EGFRvIII-Positive Glioblastoma
A Phase II Study of Rindopepimut/GM-CSF in Patients With Relapsed EGFRvIII-Positive Glioblastoma
Status: Enrolling
Updated: 4/6/2017
Swedish Neuroscience Research
961
mi
from 91732
Seattle, WA
Click here to add this to my saved trials
A Study of Rindopepimut/GM-CSF in Patients With Relapsed EGFRvIII-Positive Glioblastoma
A Phase II Study of Rindopepimut/GM-CSF in Patients With Relapsed EGFRvIII-Positive Glioblastoma
Status: Enrolling
Updated:  4/6/2017
2136
mi
from 91732
Tampa, FL
A Study of Rindopepimut/GM-CSF in Patients With Relapsed EGFRvIII-Positive Glioblastoma
A Phase II Study of Rindopepimut/GM-CSF in Patients With Relapsed EGFRvIII-Positive Glioblastoma
Status: Enrolling
Updated: 4/6/2017
Tampa General Hospital
2136
mi
from 91732
Tampa, FL
Click here to add this to my saved trials
A Study of Rindopepimut/GM-CSF in Patients With Relapsed EGFRvIII-Positive Glioblastoma
A Phase II Study of Rindopepimut/GM-CSF in Patients With Relapsed EGFRvIII-Positive Glioblastoma
Status: Enrolling
Updated:  4/6/2017
1212
mi
from 91732
Austin, TX
A Study of Rindopepimut/GM-CSF in Patients With Relapsed EGFRvIII-Positive Glioblastoma
A Phase II Study of Rindopepimut/GM-CSF in Patients With Relapsed EGFRvIII-Positive Glioblastoma
Status: Enrolling
Updated: 4/6/2017
Texas Oncology Midtown
1212
mi
from 91732
Austin, TX
Click here to add this to my saved trials
A Study of Rindopepimut/GM-CSF in Patients With Relapsed EGFRvIII-Positive Glioblastoma
A Phase II Study of Rindopepimut/GM-CSF in Patients With Relapsed EGFRvIII-Positive Glioblastoma
Status: Enrolling
Updated:  4/6/2017
2469
mi
from 91732
Commack, NY
A Study of Rindopepimut/GM-CSF in Patients With Relapsed EGFRvIII-Positive Glioblastoma
A Phase II Study of Rindopepimut/GM-CSF in Patients With Relapsed EGFRvIII-Positive Glioblastoma
Status: Enrolling
Updated: 4/6/2017
The Long Island Brain Tumor Center at Neurology Surgery, P.C.
2469
mi
from 91732
Commack, NY
Click here to add this to my saved trials
A Study of Rindopepimut/GM-CSF in Patients With Relapsed EGFRvIII-Positive Glioblastoma
A Phase II Study of Rindopepimut/GM-CSF in Patients With Relapsed EGFRvIII-Positive Glioblastoma
Status: Enrolling
Updated:  4/6/2017
2203
mi
from 91732
Durham, NC
A Study of Rindopepimut/GM-CSF in Patients With Relapsed EGFRvIII-Positive Glioblastoma
A Phase II Study of Rindopepimut/GM-CSF in Patients With Relapsed EGFRvIII-Positive Glioblastoma
Status: Enrolling
Updated: 4/6/2017
Preston Robert Tisch Brain Tumor Center at Duke University Medical Center
2203
mi
from 91732
Durham, NC
Click here to add this to my saved trials
A Study of Rindopepimut/GM-CSF in Patients With Relapsed EGFRvIII-Positive Glioblastoma
A Phase II Study of Rindopepimut/GM-CSF in Patients With Relapsed EGFRvIII-Positive Glioblastoma
Status: Enrolling
Updated:  4/6/2017
21
mi
from 91732
Orange, CA
A Study of Rindopepimut/GM-CSF in Patients With Relapsed EGFRvIII-Positive Glioblastoma
A Phase II Study of Rindopepimut/GM-CSF in Patients With Relapsed EGFRvIII-Positive Glioblastoma
Status: Enrolling
Updated: 4/6/2017
UC Irvine Chao Family Comprehensive Cancer Center
21
mi
from 91732
Orange, CA
Click here to add this to my saved trials
A Study of Rindopepimut/GM-CSF in Patients With Relapsed EGFRvIII-Positive Glioblastoma
A Phase II Study of Rindopepimut/GM-CSF in Patients With Relapsed EGFRvIII-Positive Glioblastoma
Status: Enrolling
Updated:  4/6/2017
1777
mi
from 91732
Birmingham, AL
A Study of Rindopepimut/GM-CSF in Patients With Relapsed EGFRvIII-Positive Glioblastoma
A Phase II Study of Rindopepimut/GM-CSF in Patients With Relapsed EGFRvIII-Positive Glioblastoma
Status: Enrolling
Updated: 4/6/2017
University of Alabama at Birmingham
1777
mi
from 91732
Birmingham, AL
Click here to add this to my saved trials
A Study of Rindopepimut/GM-CSF in Patients With Relapsed EGFRvIII-Positive Glioblastoma
A Phase II Study of Rindopepimut/GM-CSF in Patients With Relapsed EGFRvIII-Positive Glioblastoma
Status: Enrolling
Updated:  4/6/2017
1730
mi
from 91732
Chicago, IL
A Study of Rindopepimut/GM-CSF in Patients With Relapsed EGFRvIII-Positive Glioblastoma
A Phase II Study of Rindopepimut/GM-CSF in Patients With Relapsed EGFRvIII-Positive Glioblastoma
Status: Enrolling
Updated: 4/6/2017
University of Chicago
1730
mi
from 91732
Chicago, IL
Click here to add this to my saved trials
A Study of Rindopepimut/GM-CSF in Patients With Relapsed EGFRvIII-Positive Glioblastoma
A Phase II Study of Rindopepimut/GM-CSF in Patients With Relapsed EGFRvIII-Positive Glioblastoma
Status: Enrolling
Updated:  4/6/2017
1880
mi
from 91732
Cincinnati, OH
A Study of Rindopepimut/GM-CSF in Patients With Relapsed EGFRvIII-Positive Glioblastoma
A Phase II Study of Rindopepimut/GM-CSF in Patients With Relapsed EGFRvIII-Positive Glioblastoma
Status: Enrolling
Updated: 4/6/2017
University of Cincinnati Cancer Institute
1880
mi
from 91732
Cincinnati, OH
Click here to add this to my saved trials
A Study of Rindopepimut/GM-CSF in Patients With Relapsed EGFRvIII-Positive Glioblastoma
A Phase II Study of Rindopepimut/GM-CSF in Patients With Relapsed EGFRvIII-Positive Glioblastoma
Status: Enrolling
Updated:  4/6/2017
825
mi
from 91732
Aurora, CO
A Study of Rindopepimut/GM-CSF in Patients With Relapsed EGFRvIII-Positive Glioblastoma
A Phase II Study of Rindopepimut/GM-CSF in Patients With Relapsed EGFRvIII-Positive Glioblastoma
Status: Enrolling
Updated: 4/6/2017
University of Colorado Denver
825
mi
from 91732
Aurora, CO
Click here to add this to my saved trials
A Study of Rindopepimut/GM-CSF in Patients With Relapsed EGFRvIII-Positive Glioblastoma
A Phase II Study of Rindopepimut/GM-CSF in Patients With Relapsed EGFRvIII-Positive Glioblastoma
Status: Enrolling
Updated:  4/6/2017
1932
mi
from 91732
Ann Arbor, MI
A Study of Rindopepimut/GM-CSF in Patients With Relapsed EGFRvIII-Positive Glioblastoma
A Phase II Study of Rindopepimut/GM-CSF in Patients With Relapsed EGFRvIII-Positive Glioblastoma
Status: Enrolling
Updated: 4/6/2017
University of Michigan Comprehensive Cancer Center
1932
mi
from 91732
Ann Arbor, MI
Click here to add this to my saved trials
A Study of Rindopepimut/GM-CSF in Patients With Relapsed EGFRvIII-Positive Glioblastoma
A Phase II Study of Rindopepimut/GM-CSF in Patients With Relapsed EGFRvIII-Positive Glioblastoma
Status: Enrolling
Updated:  4/6/2017
2373
mi
from 91732
Philadelphia, PA
A Study of Rindopepimut/GM-CSF in Patients With Relapsed EGFRvIII-Positive Glioblastoma
A Phase II Study of Rindopepimut/GM-CSF in Patients With Relapsed EGFRvIII-Positive Glioblastoma
Status: Enrolling
Updated: 4/6/2017
Univ of Pennsylvania
2373
mi
from 91732
Philadelphia, PA
Click here to add this to my saved trials
A Study of Rindopepimut/GM-CSF in Patients With Relapsed EGFRvIII-Positive Glioblastoma
A Phase II Study of Rindopepimut/GM-CSF in Patients With Relapsed EGFRvIII-Positive Glioblastoma
Status: Enrolling
Updated:  4/6/2017
2122
mi
from 91732
Pittsburgh, PA
A Study of Rindopepimut/GM-CSF in Patients With Relapsed EGFRvIII-Positive Glioblastoma
A Phase II Study of Rindopepimut/GM-CSF in Patients With Relapsed EGFRvIII-Positive Glioblastoma
Status: Enrolling
Updated: 4/6/2017
University of Pittsburgh Cancer Institute
2122
mi
from 91732
Pittsburgh, PA
Click here to add this to my saved trials
A Study of Rindopepimut/GM-CSF in Patients With Relapsed EGFRvIII-Positive Glioblastoma
A Phase II Study of Rindopepimut/GM-CSF in Patients With Relapsed EGFRvIII-Positive Glioblastoma
Status: Enrolling
Updated:  4/6/2017
2244
mi
from 91732
Rochester, NY
A Study of Rindopepimut/GM-CSF in Patients With Relapsed EGFRvIII-Positive Glioblastoma
A Phase II Study of Rindopepimut/GM-CSF in Patients With Relapsed EGFRvIII-Positive Glioblastoma
Status: Enrolling
Updated: 4/6/2017
Univ of Rochester Medical Center
2244
mi
from 91732
Rochester, NY
Click here to add this to my saved trials
A Study of Rindopepimut/GM-CSF in Patients With Relapsed EGFRvIII-Positive Glioblastoma
A Phase II Study of Rindopepimut/GM-CSF in Patients With Relapsed EGFRvIII-Positive Glioblastoma
Status: Enrolling
Updated:  4/6/2017
11
mi
from 91732
Los Angeles, CA
A Study of Rindopepimut/GM-CSF in Patients With Relapsed EGFRvIII-Positive Glioblastoma
A Phase II Study of Rindopepimut/GM-CSF in Patients With Relapsed EGFRvIII-Positive Glioblastoma
Status: Enrolling
Updated: 4/6/2017
University of Southern California (U.S.C.)/ Norris Comprehensive Cancer Center
11
mi
from 91732
Los Angeles, CA
Click here to add this to my saved trials
A Study of Rindopepimut/GM-CSF in Patients With Relapsed EGFRvIII-Positive Glioblastoma
A Phase II Study of Rindopepimut/GM-CSF in Patients With Relapsed EGFRvIII-Positive Glioblastoma
Status: Enrolling
Updated:  4/6/2017
964
mi
from 91732
Seattle, WA
A Study of Rindopepimut/GM-CSF in Patients With Relapsed EGFRvIII-Positive Glioblastoma
A Phase II Study of Rindopepimut/GM-CSF in Patients With Relapsed EGFRvIII-Positive Glioblastoma
Status: Enrolling
Updated: 4/6/2017
University of Washington Medical Center
964
mi
from 91732
Seattle, WA
Click here to add this to my saved trials
A Study of Rindopepimut/GM-CSF in Patients With Relapsed EGFRvIII-Positive Glioblastoma
A Phase II Study of Rindopepimut/GM-CSF in Patients With Relapsed EGFRvIII-Positive Glioblastoma
Status: Enrolling
Updated:  4/6/2017
1358
mi
from 91732
Houston, TX
A Study of Rindopepimut/GM-CSF in Patients With Relapsed EGFRvIII-Positive Glioblastoma
A Phase II Study of Rindopepimut/GM-CSF in Patients With Relapsed EGFRvIII-Positive Glioblastoma
Status: Enrolling
Updated: 4/6/2017
UT Health Science Center, Houston Memorial Hermann Hospital, 6400 Fannin Street, #2800
1358
mi
from 91732
Houston, TX
Click here to add this to my saved trials
A Study of Rindopepimut/GM-CSF in Patients With Relapsed EGFRvIII-Positive Glioblastoma
A Phase II Study of Rindopepimut/GM-CSF in Patients With Relapsed EGFRvIII-Positive Glioblastoma
Status: Enrolling
Updated:  4/6/2017
569
mi
from 91732
Salt Lake City, UT
A Study of Rindopepimut/GM-CSF in Patients With Relapsed EGFRvIII-Positive Glioblastoma
A Phase II Study of Rindopepimut/GM-CSF in Patients With Relapsed EGFRvIII-Positive Glioblastoma
Status: Enrolling
Updated: 4/6/2017
Utah Cancer Specialists
569
mi
from 91732
Salt Lake City, UT
Click here to add this to my saved trials
A Study of Rindopepimut/GM-CSF in Patients With Relapsed EGFRvIII-Positive Glioblastoma
A Phase II Study of Rindopepimut/GM-CSF in Patients With Relapsed EGFRvIII-Positive Glioblastoma
Status: Enrolling
Updated:  4/6/2017
1762
mi
from 91732
Nashville, TN
A Study of Rindopepimut/GM-CSF in Patients With Relapsed EGFRvIII-Positive Glioblastoma
A Phase II Study of Rindopepimut/GM-CSF in Patients With Relapsed EGFRvIII-Positive Glioblastoma
Status: Enrolling
Updated: 4/6/2017
Vanderbilt-Ingram Cancer Center
1762
mi
from 91732
Nashville, TN
Click here to add this to my saved trials
A Study of Rindopepimut/GM-CSF in Patients With Relapsed EGFRvIII-Positive Glioblastoma
A Phase II Study of Rindopepimut/GM-CSF in Patients With Relapsed EGFRvIII-Positive Glioblastoma
Status: Enrolling
Updated:  4/6/2017
2126
mi
from 91732
Winston-Salem, NC
A Study of Rindopepimut/GM-CSF in Patients With Relapsed EGFRvIII-Positive Glioblastoma
A Phase II Study of Rindopepimut/GM-CSF in Patients With Relapsed EGFRvIII-Positive Glioblastoma
Status: Enrolling
Updated: 4/6/2017
Wake Forest Baptist Health
2126
mi
from 91732
Winston-Salem, NC
Click here to add this to my saved trials
A Study of Rindopepimut/GM-CSF in Patients With Relapsed EGFRvIII-Positive Glioblastoma
A Phase II Study of Rindopepimut/GM-CSF in Patients With Relapsed EGFRvIII-Positive Glioblastoma
Status: Enrolling
Updated:  4/6/2017
356
mi
from 91732
San Francisco, CA
A Study of Rindopepimut/GM-CSF in Patients With Relapsed EGFRvIII-Positive Glioblastoma
A Phase II Study of Rindopepimut/GM-CSF in Patients With Relapsed EGFRvIII-Positive Glioblastoma
Status: Enrolling
Updated: 4/6/2017
University of California at San Francisco
356
mi
from 91732
San Francisco, CA
Click here to add this to my saved trials
A Study of Rindopepimut/GM-CSF in Patients With Relapsed EGFRvIII-Positive Glioblastoma
A Phase II Study of Rindopepimut/GM-CSF in Patients With Relapsed EGFRvIII-Positive Glioblastoma
Status: Enrolling
Updated:  4/6/2017
2302
mi
from 91732
Baltimore, MD
A Study of Rindopepimut/GM-CSF in Patients With Relapsed EGFRvIII-Positive Glioblastoma
A Phase II Study of Rindopepimut/GM-CSF in Patients With Relapsed EGFRvIII-Positive Glioblastoma
Status: Enrolling
Updated: 4/6/2017
Johns Hopkins Hospital
2302
mi
from 91732
Baltimore, MD
Click here to add this to my saved trials
A Study of Rindopepimut/GM-CSF in Patients With Relapsed EGFRvIII-Positive Glioblastoma
A Phase II Study of Rindopepimut/GM-CSF in Patients With Relapsed EGFRvIII-Positive Glioblastoma
Status: Enrolling
Updated:  4/6/2017
1570
mi
from 91732
St. Louis, MO
A Study of Rindopepimut/GM-CSF in Patients With Relapsed EGFRvIII-Positive Glioblastoma
A Phase II Study of Rindopepimut/GM-CSF in Patients With Relapsed EGFRvIII-Positive Glioblastoma
Status: Enrolling
Updated: 4/6/2017
Washington University School of Medicine
1570
mi
from 91732
St. Louis, MO
Click here to add this to my saved trials
A Study of Rindopepimut/GM-CSF in Patients With Relapsed EGFRvIII-Positive Glioblastoma
A Phase II Study of Rindopepimut/GM-CSF in Patients With Relapsed EGFRvIII-Positive Glioblastoma
Status: Enrolling
Updated:  4/6/2017
2036
mi
from 91732
Cleveland, OH
A Study of Rindopepimut/GM-CSF in Patients With Relapsed EGFRvIII-Positive Glioblastoma
A Phase II Study of Rindopepimut/GM-CSF in Patients With Relapsed EGFRvIII-Positive Glioblastoma
Status: Enrolling
Updated: 4/6/2017
Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center
2036
mi
from 91732
Cleveland, OH
Click here to add this to my saved trials
A Phase I Trial Of The Humanized Anti-GD2 Antibody In Children And Adolescents With Neuroblastoma, Osteosarcoma, Ewing Sarcoma and Melanoma
A Phase I Trial Of The Humanized Anti-GD2 Antibody (HU14.18K322A) In Children And Adolescents With Neuroblastoma, Osteosarcoma, Ewing Sarcoma and Melanoma
Status: Enrolling
Updated:  4/10/2017
1587
mi
from 91732
Memphis, TN
A Phase I Trial Of The Humanized Anti-GD2 Antibody In Children And Adolescents With Neuroblastoma, Osteosarcoma, Ewing Sarcoma and Melanoma
A Phase I Trial Of The Humanized Anti-GD2 Antibody (HU14.18K322A) In Children And Adolescents With Neuroblastoma, Osteosarcoma, Ewing Sarcoma and Melanoma
Status: Enrolling
Updated: 4/10/2017
St. Jude Children's Research Hospital
1587
mi
from 91732
Memphis, TN
Click here to add this to my saved trials
Analgesia Regimens Following Trans-sphenoidal Surgery for Pituitary Tumors
Randomized, Double-Blind, Placebo-Controlled Trial Comparing Opioid-Sparing and Opioid-Containing Analgesia Regimens Following Trans-sphenoidal Surgery for Pituitary Tumors
Status: Enrolling
Updated:  4/12/2017
342
mi
from 91732
Phoenix, AZ
Analgesia Regimens Following Trans-sphenoidal Surgery for Pituitary Tumors
Randomized, Double-Blind, Placebo-Controlled Trial Comparing Opioid-Sparing and Opioid-Containing Analgesia Regimens Following Trans-sphenoidal Surgery for Pituitary Tumors
Status: Enrolling
Updated: 4/12/2017
St. Joseph's Hospital and Medical Center
342
mi
from 91732
Phoenix, AZ
Click here to add this to my saved trials
Retinoblastoma Survivor Study: Assessment of General Health and Quality of Life
Retinoblastoma Survivor Study: Assessment of General Health and Quality of Life
Status: Enrolling
Updated:  4/18/2017
2434
mi
from 91732
New York, NY
Retinoblastoma Survivor Study: Assessment of General Health and Quality of Life
Retinoblastoma Survivor Study: Assessment of General Health and Quality of Life
Status: Enrolling
Updated: 4/18/2017
Memorial Sloan Kettering Cancer Center
2434
mi
from 91732
New York, NY
Click here to add this to my saved trials
Intravenous Anesthesia Versus Anesthesia With Volatile Agents in Elective Craniotomy for Tumors
Effect of Total Intravenous Anesthesia Versus Anesthesia With Volatile Agents on Inflammatory Markers Following Elective Craniotomy for Primary Brain Tumor
Status: Enrolling
Updated:  4/19/2017
2033
mi
from 91732
Cleveland, OH
Intravenous Anesthesia Versus Anesthesia With Volatile Agents in Elective Craniotomy for Tumors
Effect of Total Intravenous Anesthesia Versus Anesthesia With Volatile Agents on Inflammatory Markers Following Elective Craniotomy for Primary Brain Tumor
Status: Enrolling
Updated: 4/19/2017
Cleveland Clinic Foundation
2033
mi
from 91732
Cleveland, OH
Click here to add this to my saved trials
Working Memory Performance Among Childhood Brain Tumor Survivors
Working Memory Performance Among Childhood Brain Tumor Survivors Treated With Conformal Radiation Therapy: A Pilot Study
Status: Enrolling
Updated:  4/24/2017
1587
mi
from 91732
Memphis, TN
Working Memory Performance Among Childhood Brain Tumor Survivors
Working Memory Performance Among Childhood Brain Tumor Survivors Treated With Conformal Radiation Therapy: A Pilot Study
Status: Enrolling
Updated: 4/24/2017
St. Jude Children's Research Hospital
1587
mi
from 91732
Memphis, TN
Click here to add this to my saved trials
Safety and Efficacy Study of In-111 Pentetreotide to Treat Neuroendocrine Tumors
High Dose Indium-111 Pentetreotide Therapy in Somatostatin Receptor Expressing Neuroendocrine Neoplasms.
Status: Enrolling
Updated:  4/27/2017
1347
mi
from 91732
Houston, TX
Safety and Efficacy Study of In-111 Pentetreotide to Treat Neuroendocrine Tumors
High Dose Indium-111 Pentetreotide Therapy in Somatostatin Receptor Expressing Neuroendocrine Neoplasms.
Status: Enrolling
Updated: 4/27/2017
Excel Diagnostic Imaging Clinics
1347
mi
from 91732
Houston, TX
Click here to add this to my saved trials
Safety and Efficacy Study of In-111 Pentetreotide to Treat Neuroendocrine Tumors
High Dose Indium-111 Pentetreotide Therapy in Somatostatin Receptor Expressing Neuroendocrine Neoplasms.
Status: Enrolling
Updated:  4/27/2017
1357
mi
from 91732
Houston, TX
Safety and Efficacy Study of In-111 Pentetreotide to Treat Neuroendocrine Tumors
High Dose Indium-111 Pentetreotide Therapy in Somatostatin Receptor Expressing Neuroendocrine Neoplasms.
Status: Enrolling
Updated: 4/27/2017
St. Luke's Episcopal Hospital
1357
mi
from 91732
Houston, TX
Click here to add this to my saved trials